͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | The next round of our Broadening Horizons mentorship programme is now open. Created by our innovation arm, Cancer Research Horizons, Wellcome and Moving Ahead, this programme will equip you with the knowledge and tools to kick-start your translational research journey.
As a mentee, you’ll be connected to mentors from industry, policy and the third sector, setting you up with useful guidance and the confidence to take your research further.
Applications close on 30 April. |
| | |
|
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
| | Join the newly launched ECMC TYA Trials Advisory Group |
| Access to clinical trials remains a significant challenge for teenagers and young adults (TYA) affected by cancer. A lack of awareness about available trials is a key barrier, limiting their opportunities to participate.
To address this, the ECMC network launched the TYA Trials Advisory Group – a forum for discussing complex TYA patient cases and identifying the most suitable treatment or trial referral pathways.
The group will run via an online platform, allowing real-time discussions while supporting existing multi-disciplinary teams (MDTs). It will also bring together experts from disease-specific MDTs and clinicians specialising in the most common TYA cancers spanning paediatric and adult care.
If you have a TYA patient case and would like to know more about the group, contact Sumair Nizamuddin. |
| | |
|
|
|
|
|
| | | | | The UK Oncology Forum is a free meeting for UK healthcare professionals (HCPs) taking place 12–13 June in Harrogate. As the UK’s only national, clinically focused, pan-tumour meeting, it serves as a crucial educational event for oncology HCPs in the UK.
On 12 June, our Data Community Support Unit will host the morning session to foster collaborations and explore innovative pathways for data and samples reuse in oncology research. Sign up for the event and register for our morning session. Your insights will help us create solutions to enhance data-sharing practices. | | |
| | | | | | | Do you want to share your early detection work with the international research community?
At this year’s Early Detection of Cancer Conference, from 21-23 October in Portland, US, we’re offering more opportunities than ever before to showcase your work, with posters, lightning talks and the all-new fun and fast-paced poster pitch sessions.
Submit your abstracts to be considered for these opportunities by 6 June. | | |
|
|---|
|
|
|
|
Answering your questions on our environmental sustainability in research policy
|
| As researchers and organisations seek to manage and reduce the environmental impact of their work where possible, we’re answering your questions on how our environmental sustainability in research policy will affect you.
These FAQs will help you understand the requirements coming into place from 1 January 2026, and who they apply to, so your funding application can be considered eligible.
We encourage response-mode grant funding applicants as well as staff at host institutions to review the policy. |
| | |
|
|
|
| | | | | A refreshed Concordat to Support Research Integrity has now been published. Thank you to everyone in our research community who took part in the consultation and provided valuable feedback.
The concordat has been in place since 2012, and this review aimed to make sure it remains relevant and applicable in today’s fast-moving research environment.
Users will find that its basic structure and requirements are unchanged, retaining the five commitments and five principles of research integrity. | | |
| | | | | | | NICE Advice offers trusted expertise to help ensure your research drives real change for patients and the NHS.
NICE Advice can support you to focus on what matters most to patients and healthcare systems, generate evidence that resonates with national decision-makers, such as NICE and navigate the path from research to NHS implementation.
Ready to maximise the impact of your cancer research? | | |
|
|---|
|
|
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
